This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Deutsches Primatenzentrum Gmbh Leibniz-Institut Für Primatenforschung. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Jens Gruber: Innovator in Virus Targeting Technology
Introduction
Jens Gruber is a notable inventor based in Göttingen, Germany. He has made significant contributions to the field of virology, particularly in the development of methods for producing virus-like particles. His innovative work has the potential to impact medical applications significantly.
Latest Patents
Jens Gruber holds a patent for a method of producing a polyomavirus or polyomavirus-derived virus-like particle (VLP) that carries at least one targeting molecule on its surface. This targeting molecule binds to specific cells of interest, enhancing the effectiveness of the VLP in medical applications. The patent also includes a composition comprising such a VLP and outlines its use as a medicament. Additionally, it describes a kit that includes the VLP or the composition, showcasing the practical applications of his invention.
Career Highlights
Throughout his career, Jens Gruber has worked with esteemed organizations such as the Deutsches Primatenzentrum GmbH Leibniz-Institut für Primatenforschung and the Deutsches Primatenzentrum. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Jens Gruber has collaborated with notable colleagues, including Stefan Schneider and Alina Mosblech. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of scientific knowledge.
Conclusion
Jens Gruber's contributions to the field of virology through his innovative patent and collaborative efforts highlight his role as a significant inventor. His work continues to pave the way for advancements in medical applications involving virus-like particles.